Literature DB >> 25209180

Significance of -1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression.

Lyuba D Miteva1, Noyko S Stanilov, Tashko S Deliysky, Spaska A Stanilova.   

Abstract

The role of functional polymorphism within IL10 (rs1800896) in colorectal cancer (CRC) still remains elusive. The aim of present study was to investigate the significance of -1082A/G polymorphism in IL10 on CRC risk, progression, and overall survival in a cohort of Bulgarian patients. Also, a functional role of this polymorphism on systemic and local level of IL10 mRNA quantity and serum IL-10 level was explored. A group of 119 patients with sporadic CRC and 154 age-sex-matched controls were genotyped by allele-specific PCR. The quantification of mRNA and serum IL-10 levels was performed by real-time PCR and ELISA assays, respectively. The genotype and allelic frequency among cases and controls was similar. However, we observed significant elevation of G-allele and GG-genotype frequencies among advanced CRC. G-allele was overrepresented in advanced CRC patients (49 %) compared to early CRC (35 %) with OR = 1.77; 95%CI 1.018 ÷ 3.083; P = 0.031. A significant upregulated expression of IL10 mRNA was observed among AG/GG-genotypes in tumor tissue compared to homozygous AA-genotype (RQ value 68.3 vs. 6.68; P = 0.0062). Also, GG-genotype of -1082A/G polymorphism in IL10 was positively associated with higher serum IL-10 among early CRC patients and controls, in contrast to advanced cases. Although, investigated polymorphism in IL10 has no significant impact of overall survival among Bulgarian CRC patients, we found a significant relationship of high pre-operative serum level of IL-10 with poor survival of CRC (P = 0.023). Our findings indicate a significant impact of -1082A/G polymorphism of IL10 on CRC progression, rather than genetic predisposition and prognosis of CRC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25209180     DOI: 10.1007/s13277-014-2589-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  26 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility.

Authors:  Spaska A Stanilova; Lyuba D Miteva; Zhivko T Karakolev; Chavdar S Stefanov
Journal:  Intensive Care Med       Date:  2006-01-25       Impact factor: 17.440

Review 3.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

4.  Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.

Authors:  F De Vita; M Orditura; G Galizia; C Romano; S Infusino; A Auriemma; E Lieto; G Catalano
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

Review 5.  Immune microenvironments in solid tumors: new targets for therapy.

Authors:  Stephen L Shiao; A Preethi Ganesan; Hope S Rugo; Lisa M Coussens
Journal:  Genes Dev       Date:  2011-12-15       Impact factor: 11.361

6.  Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.

Authors:  Antonino Crivello; Antonio Giacalone; Marina Vaglica; Letizia Scola; Giusi Irma Forte; Maria Catena Macaluso; Cristina Raimondi; Laura Di Noto; Alberto Bongiovanni; Angela Accardo; Giuseppina Candore; Laura Palmeri; Roberto Verna; Calogero Caruso; Domenico Lio; Sergio Palmeri
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

7.  Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.

Authors:  Tamara Cacev; Senka Radosević; Simun Krizanac; Sanja Kapitanović
Journal:  Carcinogenesis       Date:  2008-07-14       Impact factor: 4.944

8.  Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.

Authors:  Anna Szaflarska; Antoni Szczepanik; Maciej Siedlar; Antoni Czupryna; Marek Sierzega; Tadeusz Popiela; Marek Zembala
Journal:  Anticancer Res       Date:  2009-12       Impact factor: 2.480

9.  Cytokine promoter polymorphisms and risk of colorectal cancer.

Authors:  Florin Burada; Theodor Dumitrescu; Raluca Nicoli; Marius Eugen Ciurea; Ion Rogoveanu; Mihai Ioana
Journal:  Clin Lab       Date:  2013       Impact factor: 1.138

Review 10.  Regulatory lymphocytes and intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

View more
  18 in total

1.  Towards Identifying Genetic Biomarkers for Gastrointestinal Dysfunction in Autism.

Authors:  A E Shindler; E L Hill-Yardin; S Petrovski; N Bishop; A E Franks
Journal:  J Autism Dev Disord       Date:  2020-01

Review 2.  Targeting JAK kinase in solid tumors: emerging opportunities and challenges.

Authors:  M Buchert; C J Burns; M Ernst
Journal:  Oncogene       Date:  2015-05-18       Impact factor: 9.867

3.  Upregulation of Treg-Related Genes in Addition with IL6 Showed the Significant Role for the Distant Metastasis in Colorectal Cancer.

Authors:  L D Miteva; N S Stanilov; G М Cirovski; Spaska Angelova Stanilova
Journal:  Cancer Microenviron       Date:  2017-09-03

4.  TNF-α and IL10 polymorphisms interaction increases the risk of ankylosing spondylitis in Chinese Han population.

Authors:  Nai-Guo Wang; Da-Chuan Wang; Bing-Yi Tan; Feng Wang; Ze-Nong Yuan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

5.  The influence of the CHIEF pathway on colorectal cancer-specific mortality.

Authors:  Martha L Slattery; Abbie Lundgreen
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

6.  The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis.

Authors:  Yan-Hui Shi; Dong-Mei Zhao; Yue-Fei Wang; Xue Li; Man-Ru Ji; Dan-Na Jiang; Bai-Ping Xu; Li Zhou; Chang-Zhu Lu; Bin Wang
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

7.  Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis.

Authors:  Matheus Braga; Fernanda Formaggi Lara-Armi; Janisleya Silva Ferreira Neves; Marco Antônio Rocha-Loures; Mariana de Souza Terron-Monich; Larissa Danielle Bahls-Pinto; Quirino Alves de Lima Neto; Joana Maira Valentini Zacarias; Ana Maria Sell; Jeane Eliete Laguila Visentainer
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

8.  Modulation of Cytokines Production by Indomethacin Acute Dose during the Evolution of Ehrlich Ascites Tumor in Mice.

Authors:  Luciana Boffoni Gentile; Nicolle Queiroz-Hazarbassanov; Cristina de Oliveira Massoco; Denise Fecchio
Journal:  Mediators Inflamm       Date:  2015-08-12       Impact factor: 4.711

Review 9.  Cytokine-Induced Modulation of Colorectal Cancer.

Authors:  Lukas F Mager; Marie-Hélène Wasmer; Tilman T Rau; Philippe Krebs
Journal:  Front Oncol       Date:  2016-04-19       Impact factor: 6.244

10.  A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer.

Authors:  Chenguang Li; Xiaofan Luo; Yuyang Lin; Xiuqi Tang; Limian Ling; Lei Wang; Yanfang Jiang
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.